The current role of adjuvant radiotherapy in management of medullary thyroid carcinoma: A single institute analysis
Adjuvant EBRT failed to show any significant improvement in survival outcomes and locoregional control in MTC. Further prospective randomized clinical trials are needed to validate the role of EBRT in MTC. Clinicians should proceed with caution before advising adjuvant radiotherapy in MTC and make an informed decision after weighing the pros and cons of giving adjuvant EBRT.
Authors
- Satyajeet Rath (ORCID: https://orcid.org/0000-0003-3905-4922)
- J. Bhuvana
- Vinay Shivhare
- Ankita Parikh
- U. Suryanarayan Kunikullaya
Institutions
- Gujarat Cancer & Research Institute (IN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2024-08-16
- DOI
- https://doi.org/10.4103/jcrt.jcrt_1174_23
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00